New drug released
According to a report by PTI, the first batch of anti-COVID oral drug 2-DG, developed by the DRDO, was released today by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan. The Drugs Controller General of India (DGCI) approved the 2-deoxy-D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate to severe coronavirus patients earlier this month.
“This is a great example of the scientific prowess of our country,” he said. “We do not need to be relaxed, nor should we get tired. Because this wave has come for the second time, and there is nothing definite about this. We have to take steps with full caution,” he said at the event in DRDO headquarters.
Forces lend a hand
“I am happy to say that the Medical Corps has also decided to take back its retired doctors so that our health system can be strengthened further. I heartily commend such physicians who are joining this campaign even after their service,” Singh said. The defence minister also listed efforts of the armed forces in helping civilian authorities deal with the situation across the country.
The approval of the drug has come at a time India has been grappling with a record-breaking wave of coronavirus pandemic that has stretched the country’s healthcare infrastructure to its limit.